Back

Simultaneous Multi-Omics Analysis by Direct Infusion Mass Spectrometry (SMAD-MS)

Jiang, Y.; Salladay-Perez, I.; Momenzadeh, A.; Covarrubias, A. J.; Meyer, J. G.

2023-06-29 systems biology
10.1101/2023.06.26.546628 bioRxiv
Show abstract

Combined multi-omics analysis of proteomics, metabolomics, and lipidomics requires separate liquid chromatography-mass spectrometry (LC-MS), which limits throughput and increases costs, hindering the application of mass spectrometry-based multi-omics to large-scale analyses. Here, we present single-injection multi-omics analysis by direct infusion (SMAD), an integrated platform leveraging ion mobility mass spectrometry and self-developed software tools to enable single injection multi-omics analysis without liquid chromatography. SMAD allows quantification of over 9,000 metabolite m/z features and over 1,300 proteins from the same sample in less than five minutes. We validated the efficiency and reliability of SMAD with three case studies. (1) mouse macrophages after M1/M2 polarization and senescence, (2) a pilot drug screen in human cells, and (3) large-scale high-throughput drug screening of mammalian cells in 96-well plates. Finally, relationships between proteomic and metabolomic data are discovered by machine learning and validated.

Published in Angewandte Chemie International Edition (predicted rank #20) · training set

Matching journals

The top 3 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.